Albertsons Companies Inc Dossier
|
SectorConsumer Staples IndustryGrocery Stores Beta (adjusted)0.56 Intrinsic Value $13.37median of 5 methods · middle span $6-$17based on filings through 20 Jun 2026 Market Price $11.61Price as of 30 Sep 2026 UndervaluedIntrinsic value is 15% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $5.6B Enterprise Value $14B Shares Outstanding 547.2M diluted Moat Rating Narrow Next Earnings Date13 Oct 2026 Last ex-dividend24 Jul 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Following the termination of its proposed $24.6 billion merger with Kroger in December 2024, Albertsons Companies, Inc. (ACI) has pivoted to a standalone strategy focused on digital transformation, loyalty program expansion, and productivity initiatives. While the company's valuation is low (forward P/E of ~8x) and supported by a robust $2.0 billion share repurchase program, near-term headwinds limit immediate upside. Specifically, Albertsons faces a projected 150 basis point headwind in fiscal 2026 from the Inflation Reduction Act's Medicare Drug Price Negotiation Program, leading to a soft identical sales guidance of 0.0% to 1.0%. Consequently, the stock is viewed as a Hold until organic revenue growth accelerates and margin pressures from pharmacy mix and digital fulfillment costs stabilize. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$10.00 Mean target$14.19 High · most bullish analyst$24.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario Intense price competition from non-unionized giants like Walmart and deep discounters forces Albertsons to make aggressive price investments, severely compressing gross margins. Pharmacy headwinds from the IRA and GLP-1 drug dynamics prove more severe than the anticipated 150 bps, dragging identical sales into negative territory. High debt levels (net debt to equity over 200%) and ongoing legal/settlement cash outflows restrict capital allocation flexibility, halting share repurchases. Base CaseCentral scenario Albertsons successfully stabilizes its operating margins through its '4 big bets' (digital customer experience, merchandising intelligence, labor optimization, and supply chain optimization) and scales its high-margin Albertsons Media Collective. The company executes approximately $600 million of its $2.0 billion share repurchase authorization in fiscal 2026, helping to offset flat-to-low identical sales growth (0.0% to 1.0%) and driving adjusted EPS to the guided range of $2.22 to $2.32. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |